Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35379807.
- Also identified by DOI 10.1038/s41467-022-29124-8 and PMC identifier 8980033.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Activation of the cannabinoid-1 receptor (CB<sub>1</sub>R) and the mammalian target of rapamycin complex 1 (mTORC1) in the renal proximal tubular cells (RPTCs) contributes to the development of diabetic kidney disease (DKD). However, the CB<sub>1</sub>R/mTORC1 signaling axis in the kidney has not been described yet. We show here that hyperglycemia-induced endocannabinoid/CB<sub>1</sub>R stimulation increased mTORC1 activity, enhancing the transcription of the facilitative glucose transporter 2 (GLUT2) and leading to the development of DKD in mice; this effect was ameliorated by specific RPTCs ablation of GLUT2. Conversely, CB<sub>1</sub>R maintained the normal activity of mTORC1 by preventing the cellular excess of amino acids during normoglycemia. Our findings highlight a novel molecular mechanism by which the activation of mTORC1 in RPTCs is tightly controlled by CB<sub>1</sub>R, either by enhancing the reabsorption of glucose and inducing kidney dysfunction in diabetes or by preventing amino acid uptake and maintaining normal kidney function in healthy conditions.
Medical subject headings
- Diabetic Nephropathies
- Receptor, Cannabinoid, CB1